blood vessels

Actemra gets breakthrough therapy designation for sclerodermaThe FDA has granted breakthrough therapy designation to tocilizumab (Actemra, Genentech) for the treatment of systemic sclerosis, a rare and potentially life-threatening disease with no FDA-approved therapy.
FDA approves first spray-dried sealant to stop bleedingThe FDA approved Raplixa (fibrin sealant [human]), used to help control bleeding during surgery, on April 30.
Blood vessels reorganize after face transplantsBlood vessels in face transplant recipients reorganize themselves, according to study findings that could expand the medical community’s understanding of biologic changes that occur following such transplants.